Last reviewed · How we verify
NCT04661462
Health After Covid-19 in Tyrol
Status unknown
Last updated 10 December 2020
What this trial tests
trial testing online survey in COVID-19 in 1,000 participants. Status unknown.
Timeline
30 September 2020
Primary endpoint
30 September 2021
30 September 2021
31 December 2021
Quick facts
| Lead sponsor | Medical University Innsbruck |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 30 September 2020 |
| Primary completion | 30 September 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- online survey
Conditions studied
- COVID-19 — all drugs for COVID-19 →
Sponsor
Medical University Innsbruck
Who can join
16 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the regional online questionnaire is to better understand the pattern of acute infection and the time of recovery of various symptoms.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
-
Phenotyping of Acute and Persistent Coronavirus Disease 2019 Features in the Outpatient Setting: Exploratory Analysis of an International Cross-sectional Online Survey.
Sahanic S, Tymoszuk P, Ausserhofer D, Rass V, et al · · 2022 · cited 29× · PMID 34849652 · DOI 10.1093/cid/ciab978 -
Who Is at Risk of Poor Mental Health Following Coronavirus Disease-19 Outpatient Management?
Hüfner K, Tymoszuk P, Ausserhofer D, Sahanic S, et al · · 2022 · cited 22× · PMID 35360744 · DOI 10.3389/fmed.2022.792881 -
Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae.
Rass V, Tymoszuk P, Sahanic S, Heim B, et al · · 2023 · cited 16× · PMID 37670171 · DOI 10.1007/s00405-023-08163-x -
Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey
Sahanic S, Tymoszuk P, Ausserhofer D, Rass V, et al · · 2021 · cited 1× · DOI 10.1101/2021.08.05.21261677 -
Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae
Rass V, Tymoszuk P, Sahanic S, Heim B, et al · · 2022 · DOI 10.1101/2022.06.02.22275932 -
Who is at risk of poor mental health following COVID-19 outpatient management?
Hüfner K, Tymoszuk P, Ausserhofer D, Sahanic S, et al · · 2021 · DOI 10.1101/2021.09.22.21263949
Verify or expand the search:
- PubMed search for NCT04661462
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of online survey
Trials testing the same drug.
- NCT07483905 — Interest in Nighttime Day Hospital Chemotherapy Infusions Among Gynecologic Cancer Patients · not yet recruiting
- NCT05843994 — Artificial Intelligence Patient App for RDEB SCCs · active not recruiting
- NCT05234034 — Intensity of Physical Activity Level During Daily Living: Unravelling Its Relationship With Chronic Musculoskeletal Diso · unknown
- NCT04921826 — Potential Causes of Retained Items During Surgery · unknown
- NCT04360850 — Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic · completed
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Medical University Innsbruck trials
Trials by the same sponsor.
- NCT07408726 — Monoaxial vs. Polyaxial Percutaneous Hybrid Stabilization · NA · not yet recruiting
- NCT07101107 — Socio-cognitive and Biological Responses to Maltreatment · not yet recruiting
- NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
- NCT07434648 — Comparison of Mastectomy Expander Trial · NA · not yet recruiting
- NCT07391683 — Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT04661462 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University Innsbruck
- Last refreshed: 10 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04661462.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing